JCCC Seminar Featuring Dr. Thomas Graeber
How Targeted Therapies Exploit Signaling (Src) and Metabolic (Glucose) Over-Dependencies in Cancer Homeostasis
12:00 PM - 1:00 PM
10833 Le Conte Ave.
Los Angeles, California 90095
Thomas Graeber, Ph.D.
Associate Professor, Department of Molecular and Medical Pharmacology
Member, JCCC Cancer Nanotechnology Program Area
Dr. Thomas Graeber's lab is working to understand cancer signaling from a systems viewpoint. They focus on developing genome- and proteome-wide detection assays, applying these assays to measuring and computationally modeling aberrant cancer signaling and translating their discoveries to clinical applications. In modeling cancer signaling, one of their goals is to identify minimal sets of informative components that best reflect the state of the cell and serve as molecular targets for diagnostics, imaging and patient tailored treatment.
Light lunch served.
Sponsored by the JCCC Cancer Nanotechnology Program Area.